DCF — TEXAS HEALTH HUGULEY
Enterprise Value: $139.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$139.1M
Enterprise Value
$34.4M
PV of Cash Flows
$104.7M
PV of Terminal Value
$168.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $265.3M | $20.1M | 8.0% | $5.5M | $5.0M |
| Year 2 | $273.2M | $23.4M | 9.0% | $7.7M | $6.4M |
| Year 3 | $281.4M | $26.9M | 10.0% | $10.0M | $7.5M |
| Year 4 | $289.9M | $29.2M | 10.0% | $11.4M | $7.8M |
| Year 5 | $298.6M | $30.8M | 10.0% | $12.3M | $7.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $139.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$257.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07070630231335676
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5